References
Alexander SPH, Roberts RE, Broughton BRS, Sobey CG, George CH, Stanford
SC, et al. (2018). Goals and practicalities of immunoblotting and
immunohistochemistry: A guide for submission to the British Journal of
Pharmacology. Br J Pharmacol 175: 407-411.
Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, D’Amico
G, et al. (2011). Use of the mouse aortic ring assay to study
angiogenesis. Nat Protoc 7: 89-104.
Beenken A, Eliseenkova AV, Ibrahimi OA, Olsen SK, & Mohammadi M (2012).
Plasticity in interactions of fibroblast growth factor 1 (FGF1) N
terminus with FGF receptors underlies promiscuity of FGF1. J Biol Chem
287: 3067-3078.
Beenken A, & Mohammadi M (2009). The FGF family: biology,
pathophysiology and therapy. Nat Rev Drug Discov 8: 235-253.
Bernardim B, Cal PM, Matos MJ, Oliveira BL, Martinez-Saez N, Albuquerque
IS, et al. (2016). Stoichiometric and irreversible
cysteine-selective protein modification using carbonylacrylic reagents.
Nat Commun 7: 13128.
Brill A, Elinav H, & Varon D (2004). Differential role of platelet
granular mediators in angiogenesis. Cardiovasc Res 63: 226-235.
Brocchini S, Godwin A, Balan S, Choi JW, Zloh M, & Shaunak S (2008).
Disulfide bridge based PEGylation of proteins. Adv Drug Deliv Rev
60: 3-12.
Chu H, Gao J, Chen C, Huard J, & Wang Y (2011). Injectable fibroblast
growth factor-2 coacervate for persistent angiogenesis. Proc Natl Acad
Sci 108: 13444-13449.
Chua CC, Rahimi N, Forsten-Williams K, & Nugent MA (2004). Heparan
Sulfate Proteoglycans Function as Receptors for Fibroblast Growth
Factor-2 Activation of Extracellular Signal–Regulated Kinases 1 and 2.
Circ Res 94: 316-323.
Corseaux D, Meurice T, Six I, Rugeri L, Ezekowitz MD, Rouvier P,
et al. (2000). Basic fibroblast growth factor increases tissue factor
expression in circulating monocytes and in vascular wall. Circulation
101: 2000-2006.
Das A, Huang GX, Bonkowski MS, Longchamp A, Li C, Schultz MB, et
al. (2018). Impairment of an Endothelial NAD(+)-H2S Signaling Network
Is a Reversible Cause of Vascular Aging. Cell 173: 74-89 e20.
Decker CG, Wang Y, Paluck SJ, Shen L, Loo JA, Levine AJ, et al.(2016). Fibroblast growth factor 2 dimer with superagonist in vitro
activity improves granulation tissue formation during wound healing.
Biomaterials 81: 157-168.
DeFrees S, Wang ZG, Xing R, Scott AE, Wang J, Zopf D, et al.(2006). GlycoPEGylation of recombinant therapeutic proteins produced in
Escherichia coli. Glycobiology 16: 833-843.
Dozier JK, & Distefano MD (2015). Site-Specific PEGylation of
Therapeutic Proteins. Int J Mol Sci 16: 25831-25864.
Foley TL, & Burkart MD (2007). Site-specific protein modification:
advances and applications. Curr Opin Chem Biol 11: 12-19.
Grinnell F, Ho CH, & Wysocki A (1992). Degradation of fibronectin and
vitronectin in chronic wound fluid: analysis by cell blotting,
immunoblotting, and cell adhesion assays. J Invest Dermatol 98:410-416.
Huang Z, Tan Y, Gu J, Liu Y, Song L, Niu J, et al. (2017).
Uncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning
FGF1-FGF Receptor Dimer Stability. Cell Rep 20: 1717-1728.
Johnson GL, & Lapadat R (2002). Mitogen-activated protein kinase
pathways mediated by ERK, JNK, and p38 protein kinases. Science
298: 1911-1912.
Kang CE, Tator CH, & Shoichet MS (2010). Poly(ethylene glycol)
modification enhances penetration of fibroblast growth factor 2 to
injured spinal cord tissue from an intrathecal delivery system. J
Control Release 144: 25-31.
Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, & Group NCRRGW
(2010). Animal research: reporting in vivo experiments: the ARRIVE
guidelines. Br J Pharmacol 160: 1577-1579.
Krall N, da Cruz FP, Boutureira O, & Bernardes GJ (2016).
Site-selective protein-modification chemistry for basic biology and drug
development. Nat Chem 8: 103-113.
Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, & Schultz GS (2002).
Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of
matrix metalloproteinase-1 in wound fluids are inversely correlated with
healing of pressure ulcers. Wound Repair Regen 10: 26-37.
Li X, Wang C, Xiao J, McKeehan WL, & Wang F (2016). Fibroblast growth
factors, old kids on the new block. Semin Cell Dev Biol 53:155-167.
Maddaluno L, Urwyler C, & Werner S (2017). Fibroblast growth factors:
key players in regeneration and tissue repair. Development 144:4047-4060.
McGrath JC, & Lilley E (2015). Implementing guidelines on reporting
research using animals (ARRIVE etc.): new requirements for publication
in BJP. Br J Pharmacol 172: 3189-3193.
Nguyen TH, Kim SH, Decker CG, Wong DY, Loo JA, & Maynard HD (2013). A
heparin-mimicking polymer conjugate stabilizes basic fibroblast growth
factor. Nat Chem 5: 221-227.
Olekson MA, Faulknor R, Bandekar A, Sempkowski M, Hsia HC, & Berthiaume
F (2015). SDF-1 liposomes promote sustained cell proliferation in mouse
diabetic wounds. Wound Repair Regen 23: 711-723.
Parnaud G, Taché S, Peiffer G, & Corpet DE (1999). Polyethylene-glycol
suppresses colon cancer and causes dose-dependent regression of
azoxymethane-induced aberrant crypt foci in rats. Cancer Res
59: 5143-5147.
Potente M, Gerhardt H, & Carmeliet P (2011). Basic and therapeutic
aspects of angiogenesis. Cell 146: 873-887.
Rabuka D (2010). Chemoenzymatic methods for site-specific protein
modification. Curr Opin Chem Biol 14: 790-796.
Rosen CB, & Francis MB (2017). Targeting the N terminus for
site-selective protein modification. Nat Chem Biol 13: 697-705.
Sarabipour S, & Hristova K (2016). Mechanism of FGF receptor
dimerization and activation. Nat Commun 7: 10262.
Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon
A, et al. (2000). Crystal structure of a ternary FGF-FGFR-heparin
complex reveals a dual role for heparin in FGFR binding and
dimerization. Mol Cell 6: 743-750.
Slack JM, Darlington BG, Heath JK, & Godsave SF (1987). Mesoderm
induction in early Xenopus embryos by heparin-binding growth factors.
Nature 326: 197-200.
Takahashi K, & Yamanaka S (2006). Induction of pluripotent stem cells
from mouse embryonic and adult fibroblast cultures by defined factors.
Cell 126: 663-676.
van Horssen R, Galjart N, Rens JA, Eggermont AM, & ten Hagen TL (2006).
Differential effects of matrix and growth factors on endothelial and
fibroblast motility: application of a modified cell migration assay. J
Cell Biochem 99: 1536-1552.
Xu HL, Chen PP, Wang LF, Tong MQ, Ou ZH, Zhao YZ, et al. (2018).
Skin-permeable liposome improved stability and permeability of bFGF
against skin of mice with deep second degree scald to promote hair
follicle neogenesis through inhibition of scar formation. Colloids Surf
B Biointerfaces 172: 573-585.
Zhou J, Cai X, Huang X, Dai Y, Sun L, Zhang B, et al. (2017). A
novel glucagon-like peptide-1/glucagon receptor dual agonist exhibits
weight-lowering and diabetes-protective effects. Eur J Med Chem
138: 1158-1169.